期刊
JOURNAL OF REHABILITATION MEDICINE
卷 41, 期 1, 页码 13-25出版社
FOUNDATION REHABILITATION INFORMATION
DOI: 10.2340/16501977-0303
关键词
botulinum toxin; upper motor neurone syndrome; adult spasticity; acquired brain injury
资金
- Allergan
- Ipsen
- Merz
- Elan
- Medtronic
- Novartis
- Boehringer
A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. this consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据